Fitness Trends Regenerative Medicine Market | Page 3

Major acquisitions to support growth of regenerative medicine market:
There are few recent acquisitions by the big brands in biotechnology that is expected to favor
growth of regenerative medicine industry. In August 2016, Medtronic Inc. acquired Heart Ware
International, Inc. — a provider of technologies for less-invasive, miniaturized, mechanical
circulatory support (MCS) for treatment of patients with advanced heart failure. This acquisition
is further expected to favor the working efficiency of the company and broadens its product
portfolio.
Competitor Analysis:
• Depuy Synthes Inc.
• Orthofix Inc.
• NuVasive Inc.
• Zimmer Holdings Inc.
Developed regions major growth engines of the regenerative medicine market:
Developed countries such as the U.S., Germany, U.K., France, and Japan have a highly
developed market for regenerative medicine, mainly due to technical advancements in the
region. According to Regenerative Medicine Annual Report, in 2013, in regenerative medicine
market there has been various product approvals along with annual revenue of around US$ 1
billion. Thus, this sector is expected to attract attention from investors and industry partners in
the near future. Furthermore, as per the report, around 60,000 stem cell transplants are
performed globally each year to treat various cancers and blood-based disorders. This augments
growth of the market of regenerative medicine. Also, as observed by Alliance for Regenerative
Medicine (ARM), in 2012, the bio-therapeutic companies distributing cell therapy products
generated around US$ 900 million, with 160,000 patients undergoing various related treatments.
Regenerative medicine market taxonomy:
By Technology
• Biomaterial
• Tissue Engineering
• Stem Cell Therapy